Drug development future: 3DforScience in BIOPharm America 23

5 Minutes


BIOPharm America, scheduled for September 13-14, 2023, is a dynamic event that unites the global life science community. This annual gathering provides a unique platform for professionals in the field to converge, exchange ideas, and explore potential collaborations. Renowned experts, innovators, and thought leaders from around the world assemble to engage in personalized one-to-one meetings.

3DforScience helping Digital Agencies

Ready to Outsource Work or Hire a New Studio?
Get this free Guide with 20 essentials Questions and our Tips for Making the Right Choice


3DforScience Role – Global Scientific Communication

The 23rd BIOPharm America conference will focus on cutting-edge scientific advances, investment trends, market access strategies, and sustainability in the U.S. pharmaceutical industry, among other topics. This year’s event is expected to foster lively discussions and networking opportunities that will lead the life sciences industry to a better place, with topics including accelerating innovation through research and academia working with industry, CTG development and commercialization, or dealmakers and corporate investment trends insights.

One of the primary challenges in the life sciences industry is communicating complex scientific concepts to diverse audiences effectively. 3DforScience specializes in bridging this communication gap through the power of visual storytelling. Their expertise in creating animations, 3D models, and interactive presentations allows them to transform intricate scientific data into engaging narratives, and at BIOPharm America, where precise and impactful communication is paramount, 3DforScience can play a pivotal role in helping companies and researchers convey their ideas with clarity, combining scientific accuracy with creative visualization, grasp the significance of groundbreaking innovations, fostering meaningful connections and collaborations.


Effective communication on a global scale is essential for forging international partnerships and collaborations. 3DforScience excels in this aspect by its ability to adapt content, ensuring that participants can engage with a wider audience, and break down barriers. Whether it’s a captivating video, an interactive virtual booth, or informative infographics, 3DforScience tailors its communication solutions to resonate with diverse audiences. This versatility enables companies to expand their reach and connect with potential partners from around the world.



3DforScience – Visuals for Bio&Health in BIOPharma 2023

3DforScience is a scientific communication company specializing in visual content for the life science sector.

We are a passionate creative team of scientists, marketers, artists, and animators. Our mission is to help you improve your scientific communication with innovative and unique creative solutions adapted to your business objectives.

Our objective is help to boost your scientific communication capabilities within the biotechnological/ molecular biology fields by designing unique creative solutions such as 3D animation videos or illustrations.

Would you like to bring your scientific messaging to life? Contact us. We would be pleased to provide you with a unique creation.

Ready to Outsource Work or Hire a New Studio?

Get this free Guide with 20 essentials Questions and our Tips for Making the Right Choice

How Medical Devices Work: 3D Animation to Explain It

How Medical Devices Work: 3D Animation to Explain It

Medical devices are innovative technologies that have rapidly evolved in the last decade to improve people’s quality of life. Not too far ago it would sound futuristic to receive medication from your chronic disease at home or get rid of your glasses through a rapid...

BIO Europe 2023

BIO Europe 2023

BIO Europe 2023 will be held in Munich from October 6-8 and 14-15, 2023. The event is Europe's largest gathering of biopharmaceutical professionals and an international forum for business development among pharmaceutical, financial, and biotechnology companies....